Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
A 
Agilent Technologies Inc (A)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/21/2025: A (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -13.15% | Avg. Invested days 36 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/21/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 29.94B USD | Price to earnings Ratio 23.6 | 1Y Target Price 142.76 |
Price to earnings Ratio 23.6 | 1Y Target Price 142.76 | ||
Volume (30-day avg) 1616041 | Beta 1.19 | 52 Weeks Range 96.43 - 154.20 | Updated Date 04/23/2025 |
52 Weeks Range 96.43 - 154.20 | Updated Date 04/23/2025 | ||
Dividends yield (FY) 0.96% | Basic EPS (TTM) 4.45 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 19.27% | Operating Margin (TTM) 23.2% |
Management Effectiveness
Return on Assets (TTM) 8.39% | Return on Equity (TTM) 20.61% |
Valuation
Trailing PE 23.6 | Forward PE 18.48 | Enterprise Value 31207410334 | Price to Sales(TTM) 4.58 |
Enterprise Value 31207410334 | Price to Sales(TTM) 4.58 | ||
Enterprise Value to Revenue 4.78 | Enterprise Value to EBITDA 16.83 | Shares Outstanding 285103008 | Shares Floating 284116262 |
Shares Outstanding 285103008 | Shares Floating 284116262 | ||
Percent Insiders 0.29 | Percent Institutions 91.58 |
Analyst Ratings
Rating 3.9 | Target Price 143.88 | Buy 2 | Strong Buy 8 |
Buy 2 | Strong Buy 8 | ||
Hold 10 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Agilent Technologies Inc
Company Overview
History and Background
Agilent Technologies Inc. was founded in 1999 as a spin-off from Hewlett-Packard. It focuses on life sciences, diagnostics, and applied chemical markets. It has grown through acquisitions and internal development.
Core Business Areas
- Life Sciences and Applied Markets Group (LSAG): Provides application-focused solutions including instruments, software, consumables, and services that enable customers to identify, quantify, and analyze the physical and biological properties of substances and products.
- Diagnostics and Genomics Group (DGG): Offers solutions that include reagents, instruments, software, and consumables that enable customers in the clinical and translational research settings. Focuses on areas such as cancer diagnostics, genetic testing, and companion diagnostics.
- Agilent CrossLab Group (ACG): Offers a portfolio of lab-wide services that optimize customer operations. It encompasses instrument services and support, consumables and supplies, and lab asset management
Leadership and Structure
Padraig McDonnell is the current President and CEO. The company operates with a structured organizational model that divides into the three groups mentioned above. Senior leadership manages across business segments.
Top Products and Market Share
Key Offerings
- Liquid Chromatography-Mass Spectrometry (LC/MS): Instruments and software for identifying and quantifying chemical compounds. It holds a significant market share (estimated 20-25%) in the LC/MS market. Major competitors include Waters Corporation and Thermo Fisher Scientific. Revenue generated from LC/MS and associated consumables contributes a substantial portion to Agilent's LSAG revenue.
- Market Share: 25
- Gas Chromatography (GC) Systems: Instruments and consumables used for separating and analyzing volatile compounds. Agilent holds a leading market share in GC, estimated around 40%. Key competitors include Thermo Fisher Scientific and PerkinElmer. Significant portion of the LSAG Revenue. Number of users around 200,000
- Market Share: 40
- Market Share: 10
- Next-Generation Sequencing (NGS): Solutions for genomics research, diagnostics, and clinical applications. Market share varies depending on the specific application but Agilent is a key player. Competitors include Illumina and Thermo Fisher Scientific.
Market Dynamics
Industry Overview
The analytical instrument industry is characterized by technological innovation, increasing regulatory requirements, and growing demand for testing and analysis in various sectors, including pharmaceuticals, environmental monitoring, and food safety. The industry is competitive with high barriers to entry due to the complexity of the technology and stringent regulatory standards.
Positioning
Agilent Technologies Inc. is positioned as a leading provider of analytical instruments and solutions. Its competitive advantages include a strong brand reputation, a broad product portfolio, a global service network, and a focus on innovation.
Total Addressable Market (TAM)
The total addressable market is estimated to be approximately $60 Billion. Agilent is well-positioned to capture a significant portion of this TAM with its comprehensive product portfolio and global reach.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Broad product portfolio
- Global service network
- High R&D investments
- Strong customer relationships
Weaknesses
- Vulnerable to economic cycles
- Exposure to regulatory changes
- Dependence on key suppliers
- Long sales cycles
- High operating costs
Opportunities
- Expanding into emerging markets
- Developing new applications for existing products
- Acquiring complementary technologies
- Increasing service revenues
- Focus on sustainable solutions
Threats
- Intense competition
- Rapid technological changes
- Economic downturns
- Supply chain disruptions
- Increased regulation
Competitors and Market Share
Key Competitors
- TMO
- WAT
- ILMN
- PKI
Competitive Landscape
Agilent possesses a broad product portfolio with a strong service network and innovation. However, it competes with other firms that are larger and more focused such as TMO and WAT, but Agilent is considered a key player in this industry.
Major Acquisitions
Resolution Bioscience
- Year: 2021
- Acquisition Price (USD millions): 550
- Strategic Rationale: Expanded Agilent's NGS capabilities and diagnostic solutions.
BioTek Instruments
- Year: 2019
- Acquisition Price (USD millions): 1050
- Strategic Rationale: Expanded Agilent's cell analysis and drug discovery solutions.
Growth Trajectory and Initiatives
Historical Growth: Agilent Technologies Inc. has experienced moderate growth in revenue and earnings over the past years, driven by acquisitions, product innovation, and expansion into new markets.
Future Projections: Analysts project continued growth for Agilent Technologies Inc., driven by increasing demand for analytical instruments in the life sciences and diagnostics sectors.
Recent Initiatives: Recent strategic initiatives include acquiring Resolution Bioscience for $550 million, expanding its NGS capabilities, and investing in new manufacturing facilities to increase production capacity.
Summary
Agilent Technologies Inc. is a financially stable company with a strong brand and a wide range of analytical instruments, software, and related services. The company is in a highly competitive market facing challenges in regulatory requirements and a volatile market. However, Agilent is growing into emerging markets and they continue to innovate. They need to continue to monitor and navigate regulatory changes and intense competition.
Similar Companies
DHR
Danaher Corporation
DHR
Danaher Corporation
HON
Honeywell International Inc
HON
Honeywell International Inc
ILMN
Illumina Inc
ILMN
Illumina Inc
MMM
3M Company
MMM
3M Company
TMO
Thermo Fisher Scientific Inc
TMO
Thermo Fisher Scientific Inc
WAT
Waters Corporation
WAT
Waters Corporation
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Analyst Reports (e.g., from major investment banks)
- Company Press Releases
- Industry Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It is not financial advice. Market conditions can change and past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Agilent Technologies Inc
Exchange NYSE | Headquaters Santa Clara, CA, United States | ||
IPO Launch date 1999-11-18 | CEO, President & Director Mr. Padraig McDonnell | ||
Sector Healthcare | Industry Diagnostics & Research | Full time employees 17900 | Website https://www.agilent.com |
Full time employees 17900 | Website https://www.agilent.com | ||
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. This segment also offers GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. The Diagnostics and Genomics segment provides genomics, contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses; and cell analysis plate based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, and related consumables. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.